List of bibliographic references indexed by Stimulant dopaminergique
Number of relevant bibliographic references: 45.
[20-40] [
0 - 20][
0 - 45][
40-44][
40-60]
| Ident. | Authors (with country if any) | Title |
|---|
| 003092 (2002) |
C. E. Clarke [Royaume-Uni] ; M. Guttman [Canada] | Dopamine agonist monotherapy in Parkinson's disease |
| 003310 (2001) |
Mahyar Etminan [Canada] ; Ali Samii [États-Unis] ; Bahi Takkouche [Espagne] ; Paula A. Rochon [Canada] | Increased risk of somnolence with the new dopamine agonists in Patients with Parkinson's disease: A meta-analysis of randomised controlled trials |
| 003325 (2001) |
André Parent [Canada] ; Martine Cossette [Canada] | Extrastriatal dopamine and Parkinson's disease |
| 003335 (2001) |
Oleh Hornykiewicz [Autriche] | Dopamine and Parkinson's disease: A personal view of the past, the present, and the future |
| 003336 (2001) |
Olivier Rascol [France] ; Joaquim J. Ferreira [Portugal] ; Claire Thalamas [France] ; Monique Galitsky [France] ; Jean-Louis Montastruc [France] | Dopamine agonists: Their role in the management of Parkinson's disease |
| 003351 (2001) |
Raul De La Fuente-Fernandez [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease : PET evidence of increased dopamine turnover |
| 003557 (2000) |
ABDALLAH HADJ TAHAR [Canada] ; Laurent Gregoire [Canada] ; Evelyne Bangassoro [Canada] ; Paul J. Bedard [Canada] | Sustained cabergoline treatment reverses levodopa-induced dyskinesias in parkinsonian monkeys |
| 003562 (2000) |
M. Goulet [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; S. Maltais [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada] | Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-Monkeys |
| 003599 (2000) |
O. Rascol [France] ; D. J. Brooks [Royaume-Uni] ; A. D. Korczyn [Israël] ; P. P. De Deyn [Belgique] ; C. E. Clarke [Royaume-Uni] ; A. E. Lang [Canada] | A five-year study of the incidence of dyskinesia in patients with early parkinson's disease who were treated with ropinirole or levodopa |
| 003827 (1999) |
V. D. Doan [Canada] ; R. Grondin [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; L. Gregoire [Canada] ; P. J. Bedard [Canada] | Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys |
| 003B97 (1997) |
Chien-Tsai Lai [Canada] ; Peter H. Yu [Canada] | Dopamine- and l-β-3,4-dihydroxyphenylalanine hydrochloriDe (l-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y Cells |
| 003F76 (1995) |
Céline Gagnon [Canada] ; Baltazar Gomez-Mancilla [Canada] ; Rudolf Markstein [Suisse] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors |
| 004454 (1993) |
P. Blanchet [Canada] ; P. J. Bedard [Canada] ; D. R. Britton ; J. W. Kebabian | Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys |
| 004459 (1993) |
C. Gagnon [Canada] ; B. Gomez-Mancilla ; P. J. Bedard ; T. Di Paolo [Canada] | Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors |
| 004526 (1992) |
Baltazar Gomez-Mancilla [Canada] ; Paul J. Bédard [Canada] | Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys |
| 004630 (1992) |
H. A. Robertson [Canada] ; M. R. Peterson ; G. G. Worth | Synergistic and persistent interaction between the D2 agonist, bromocriptine, and the D1 selective agonist, CY 208-243 |
| 004649 (1992) |
B. Gomez-Mancilla [Canada] ; R. Boucher ; P. J. Bedard | Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of Parkinsonism |
| 004897 (1990) |
C. Rouillard [Canada] ; P. J. Bédard [Canada] ; T. Di Paolo [Canada] | Effects of chronic treatment of MPTP monkeys with bromocriptine alone or in combination with SKF 38393 |
| 004899 (1990) |
Céline Gagnon [Canada] ; Paul J. Bédard [Canada] ; Thérèse Di Paolo [Canada] | Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists |
| 004A04 (1990) |
E. C. Wolters ; T. A. Hurwitz ; E. Mak ; P. Teal ; F. R. Peppard ; R. Remick ; S. Calne ; D. B. Calne | Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis |
| 004A05 (1990) |
A. E. Lang ; D. E. Riley ; L. Vachon ; X. Lataste | CQA 206-291 in Parkinson's disease : an acute single escalating dosage study |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Stimulant dopaminergique"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i \
-Sk "Stimulant dopaminergique" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= PascalFr.i
|clé= Stimulant dopaminergique
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 |  |
